The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I trial everolimus and sorafenib in patients with recurrent high-grade gliomas: Brain Tumor Treatment Collaborative trial 09-01.
 
Jeffrey J. Raizer
Honoraria - EMD Serono; Genentech; Midatech Pharma; Novocure; Proximagen; Stemline Therapeutics
Consulting or Advisory Role - EMD Serono; Genentech; Midatech Pharma; Novocure; Proximagen; Stemline Therapeutics
Speakers' Bureau - Genentech; Novocure
Research Funding - Celldex (Inst); Genentech (Inst); Novartis (Inst); Stemline Therapeutics (Inst)
 
Sean Aaron Grimm
Employment - Lundbeck (I)
Consulting or Advisory Role - abbvie; novocure
 
Marta Penas-Prado
Research Funding - bayer (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Novartis (Inst)
 
Ivo Tremont-Lukats
No Relationships to Disclose
 
W. K. Alfred Yung
Honoraria - Actelion; Merck
 
Nicholas George Avgeropoulos
Honoraria - Novocure
Consulting or Advisory Role - Novocure
Speakers' Bureau - Novocure
 
Tobias Walbert
No Relationships to Disclose
 
Monica Elena Loghin
No Relationships to Disclose
 
Mark R. Gilbert
Honoraria - Abbvie; Cell Medica; Genentech/Roche; HERON; Merck; Wellcome Trust
Consulting or Advisory Role - Abbvie; Cell Medica; Genentech/Roche; HERON; Merck/Schering Plough; Wellcome Trust
Research Funding - Genentech/Roche; GlaxoSmithKline; Merck/Schering Plough
Travel, Accommodations, Expenses - Abbvie; Genentech/Roche; Merck/Schering Plough